Scandipharm Overview

  • Year Founded
  • 1991

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $108M

Scandipharm General Information

Description

Provider of pharmaceutical and nutritional products. The company engages in the development, manufacturing and marketing of pharmaceuticals products and services to medical markets.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 22 Inverness Center Parkway
  • Birmingham, AL 35242
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • 22 Inverness Center Parkway
  • Birmingham, AL 35242
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Scandipharm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 10-Sep-1999 $108M Completed Profitable
1. Early Stage VC 26-Nov-1996 Completed Profitable
To view Scandipharm’s complete valuation and funding history, request access »

Scandipharm Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Claneil Enterprises Holding Company Minority
New Enterprise Associates Venture Capital Minority
To view Scandipharm’s complete investors history, request access »

Scandipharm FAQs

  • When was Scandipharm founded?

    Scandipharm was founded in 1991.

  • Where is Scandipharm headquartered?

    Scandipharm is headquartered in Birmingham, AL.

  • What industry is Scandipharm in?

    Scandipharm’s primary industry is Pharmaceuticals.

  • Is Scandipharm a private or public company?

    Scandipharm is a Private company.

  • What is the current valuation of Scandipharm?

    The current valuation of Scandipharm is .

  • What is Scandipharm’s current revenue?

    The current revenue for Scandipharm is .

  • How much funding has Scandipharm raised over time?

    Scandipharm has raised $37M.

  • Who are Scandipharm’s investors?

    Claneil Enterprises and New Enterprise Associates have invested in Scandipharm.

  • When was Scandipharm acquired?

    Scandipharm was acquired on 10-Sep-1999.

  • Who acquired Scandipharm?

    Scandipharm was acquired by Aptalis Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process